Non-small cell lung cancer in elderly – retrospective study comparing single-agent versus doublet chemotherapy
Revista do Grupo de Estudos do Cancro do Pulmão · 2020
DOI: 10.32932/gecp.2020.12.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista do Grupo de Estudos do Cancro do Pulmão, 2020. Verfasst von Élia Cipriano und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
In non -small cell lung cancer (NSCLC) elderly patients with advanced disease and without driver mutations, questions remain if they benefit from doublet chemotherapy (ChT) or single -agent ChT.
Methods
A retrospective study characterizing elderly NSCLC patients with advanced disease. The primary endpoint was overall survival (OS) after doublet ChT and single -agent ChT, calculated using Kaplan -Meier method and Log Rank test.
Results
Forty -six patients with locally advanced or metastatic disease were treated with ChT (22 with platinum- -based doublet ChT and 24 with single -agent ChT). With a median follow -up of 26.6 months (mo.), the median OS was 8.4 mo. in doublet ChT and 7.0 mo. in single‑agent ChT, p=0.441.
Conclusions
There were no statistically significant differences in survival between platinum -based doublet and monotherapy ChT in our studied population.
Zitieren
APA
Cipriano, É., Magalhães, H., & Estevinho, F. (2020). Non-small cell lung cancer in elderly – retrospective study comparing single-agent versus doublet chemotherapy. Revista do Grupo de Estudos do Cancro do Pulmão. https://doi.org/10.32932/gecp.2020.12.009
Vancouver
Cipriano É, Magalhães H, Estevinho F. Non-small cell lung cancer in elderly – retrospective study comparing single-agent versus doublet chemotherapy. Revista do Grupo de Estudos do Cancro do Pulmão. 2020. doi:10.32932/gecp.2020.12.009
BibTeX
@article{Cipriano2020,
author = {Cipriano, Élia and Magalhães, Helena and Estevinho, Fernanda},
title = {Non-small cell lung cancer in elderly – retrospective study comparing single-agent versus doublet chemotherapy},
journal = {Revista do Grupo de Estudos do Cancro do Pulmão},
year = {2020},
doi = {10.32932/gecp.2020.12.009}
}
EUVIMED